Butylated Hydroxytoluene vs Recombinant Bovine Somatotropin: which is worse?

What is Butylated Hydroxytoluene?

Butylated hydroxytoluene (BHT) is a synthetic lipophilic phenolic antioxidant preservative derived from petroleum. It is a white crystalline solid with chemical formula C15H24O. Like BHA, it prevents fat oxidation and is widely used in food, cosmetics, pharmaceuticals, jet fuel, and rubber.

What is Recombinant Bovine Somatotropin?

Recombinant bovine somatotropin (rBST) is the synthetic version of bovine growth hormone (BST), naturally produced by the pituitary gland in cattle. The recombinant version is produced using genetically engineered bacteria and is injected into dairy cows to increase milk production by 10-15%. Brand name: Posilac.

Documented risks

Butylated Hydroxytoluene: BHT's carcinogenicity profile is complex and bidirectional. Some NTP bioassays found liver tumors in female mice at high doses, while other studies suggested BHT might inhibit tumor initiation in certain contexts. A 1986 NTP bioassay found liver tumors in female mice but anti-carcinogenic effects in the rat forestomach — making BHT's net carcinogenicity uncertain. IARC has not formally classified BHT in a specific Group due to this conflicting evidence. The NTP notes that BHT's carcinogenicity data are complex. The 'Report on Carcinogens' does not currently list BHT, unlike BHA, but the NTP has noted inconclusive evidence. Potential endocrine disruption: a 2017 study in Environmental Science & Technology found BHT disrupted thyroid hormone levels in female rats. Multiple animal studies have demonstrated weak estrogenic effects. The American Academy of Pediatrics' 2018 policy statement on food additives mentioned BHT as a synthetic preservative warranting reduced childhood exposure. Kellogg's Frosted Flakes in the US contains BHT to preserve freshness; the European version uses mixed tocopherols (vitamin E) instead — a commercially meaningful difference demonstrating feasibility of substitution. Japan banned BHT for food use based on its precautionary approach. The EU restricts it with ADI-based maximum permitted levels.

Recombinant Bovine Somatotropin: See recombinant-bovine-growth-hormone-rbgh for full detail. Key concerns: rBST elevates IGF-1 in milk; elevated blood IGF-1 is associated with breast, prostate, and colorectal cancer risk in epidemiological studies. Animal welfare: increased mastitis (up to 25-50% higher rates), lameness, and antibiotic use. The Codex Alimentarius Commission declined to endorse rBST safety MRLs in a historic 33-29 vote. Health Canada rejected rBST approval in 1999 after finding it caused significant animal health problems requiring increased antibiotic use.